Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Doxofylline (20mg/ml) Syrup
Therapeutic Category
Pulmonary, Respiratory
Dosage Form
Syrup
Packaging Type
Bottle
Packaging
100ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dozyfyle Syrup containing Doxofylline is used for the management of asthma and chronic obstructive pulmonary disorders (COPD). It helps improve breathing by relaxing airway muscles and reducing bronchospasm.
Doxofylline works as a bronchodilator that inhibits phosphodiesterase activity, helping to open airways and improve airflow to the lungs with better tolerability compared to traditional xanthines.
The syrup is widely prescribed in respiratory and general medicine practice for asthma, bronchitis, and other obstructive airway conditions, leading to consistent prescription demand.
With increasing prevalence of respiratory disorders and growing demand for effective bronchodilator therapies, this product offers strong business potential for retailers and distributors. Its established respiratory safety profile, broad clinical use, and steady market demand make it a reliable product for growth in the respiratory care segment.
Some patients may experience nausea, vomiting, stomach discomfort, headache, dizziness, restlessness, palpitations, or insomnia. Rarely, cardiac rhythm disturbances or severe hypersensitivity reactions may occur and require medical attention.
Dozyfyle Syrup is indicated for bronchial asthma, chronic obstructive pulmonary disease (COPD), wheezing, bronchospasm, and other obstructive airway conditions. It helps relieve shortness of breath, chest tightness, and improves overall respiratory function.
This medicine should be used under medical supervision. Use cautiously in patients with heart disease, liver impairment, hypertension, or seizure disorders. Avoid excessive caffeine intake during treatment. Follow the prescribed dose carefully.
Store in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep the bottle tightly closed and out of reach of children.
Composition : Doxofylline (400mg)
Composition : Doxofylline (650mg) SR
Composition : Doxofylline (400mg) + Ambroxol (30mg)
Composition : Doxofylline (400mg) + Montelukast (10mg)
Composition : Acebrophylline (100mg) Capsule
Composition : Levosalbutamol 100mcg + Ipratropium 40mcg
Composition : Fluticasone Propionate 500mcg + Formoterol Fumarate 12mcg Life Cap
Composition : Budesonide (200mcg) + Formoterol (6mcg) Rota Capsule
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Doxofylline 20mg/ml Syrup has strong demand in the respiratory care, pediatric care, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on asthma and COPD management portfolios.
Medical distributors and agencies can benefit from consistent demand for bronchospasm and breathing disorder management under medical supervision. Doxofylline is a bronchodilator that helps relax airway muscles and improve airflow Commonly prescribed for bronchial asthma, COPD, wheezing, and other respiratory conditions associated with airway obstruction Syrup formulation is especially useful for children and elderly patients who have difficulty swallowing tablets Helps improve breathing comfort and reduce respiratory distress symptoms This strengthens a comprehensive respiratory care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Doxofylline 20mg/ml Syrup with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong demand in respiratory care, pediatric prescriptions, seasonal usage patterns, reliable supply chain support, and attractive margins in the asthma and COPD segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.